Basic Information
RNALocate ID: RLID:11002752
RNA Symbol: hsa-miR-18b-5p
Localization: Microvesicle
RNA Information
RNA Name: hsa-miR-18b
RNA ID: miRBase:MIMAT0001412
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 23539611
Tissue/Cell Line: Seminal plasma
Method: Microarray
Description: In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01002273 Cytoplasm Breast cancer tissue 32370743
RLID:01002274 Cytoplasm Nasopharyngeal carcinoma cells 20498841
RLID:01002275 Cytoplasm Neural progenitor cells 21363885
RLID:01002276 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:01002277 Nucleus Nasopharyngeal carcinoma cells 20498841
RLID:11002747 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11002748 Exosome Breast milk 22211110
RLID:11002749 Exosome Brain tissue 23382797
RLID:11002750 Exosome Human mast cell line (HMC-1) 24009880
RLID:11002751 Exosome Serum 25349172
RLID-D:11000450 Microvesicle Mesenchymal stem cells
RLID-D:11001225 Exosome Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-18b-5p Mantle cell lymphoma MNDR-E-MI-21905
MNDR hsa-miR-18b-5p Multiple sclerosis chronic progressive MNDR-E-MI-21906
MNDR hsa-miR-18b-5p Oral squamous cell carcinoma MNDR-E-MI-21907
MNDR hsa-miR-18b-5p Large cell neuroendocrine cancer MNDR-E-MI-21908
MNDR hsa-miR-18b-5p High-grade serous ovarian carcinoma MNDR-E-MI-21909
MNDR hsa-miR-18b-5p Ovarian clear cell carcinoma MNDR-E-MI-21910
MNDR hsa-miR-18b-5p Uterine corpus endometrial carcinoma MNDR-E-MI-21911
MNDR hsa-miR-18b-5p Lymphoma MNDR-E-MI-21912
MNDR hsa-miR-18b-5p Estrogen-receptor negative breast cancer MNDR-E-MI-21913
MNDR hsa-miR-18b-5p Progesterone-receptor negative breast cancer MNDR-E-MI-21914
MNDR hsa-miR-18b-5p Her2-receptor positive breast cancer MNDR-E-MI-21915
MNDR hsa-miR-18b-5p Prostate cancer MNDR-E-MI-21916
MNDR hsa-miR-18b-5p Gastric cancer MNDR-E-MI-21917
MNDR hsa-miR-18b-5p Alzheimer disease MNDR-E-MI-21918
MNDR hsa-miR-18b-5p Intracranial aneurysm MNDR-E-MI-21919
MNDR hsa-miR-18b-5p Sarcoma MNDR-E-MI-21920
MNDR hsa-miR-18b-5p Dysautonomia familial MNDR-E-MI-21921
MNDR hsa-miR-18b-5p Head and neck cancer MNDR-E-MI-21922
MNDR hsa-miR-18b-5p Leukemia MNDR-E-MI-21923
MNDR hsa-miR-18b-5p Cardiovascular disease MNDR-E-MI-21924
MNDR hsa-miR-18b-5p Lung cancer MNDR-E-MI-21925
MNDR hsa-miR-18b-5p Parkinson disease MNDR-E-MI-21926
MNDR hsa-miR-18b-5p Basal-like breast cancer MNDR-E-MI-21927
MNDR hsa-miR-18b-5p Thyroid cancer MNDR-E-MI-21928
MNDR hsa-miR-18b-5p Pancreatic cancer MNDR-E-MI-21929
MNDR hsa-miR-18b-5p Melanoma MNDR-E-MI-21930
MNDR hsa-miR-18b-5p Nephroblastoma MNDR-E-MI-21931
MNDR hsa-miR-18b-5p Colon cancer MNDR-E-MI-21932
MNDR hsa-miR-18b-5p Colon adenocarcinoma MNDR-E-MI-21933
MNDR hsa-miR-18b-5p Multiple sclerosis MNDR-E-MI-21934
MNDR hsa-miR-18b-5p Multiple sclerosis relapsing-remitting MNDR-E-MI-21935
MNDR hsa-miR-18b-5p Familial ovarian cancer MNDR-E-MI-21936
MNDR hsa-miR-18b-5p Prostate adenocarcinoma MNDR-E-MI-21937
MNDR hsa-miR-18b-5p Glioblastoma MNDR-E-MI-21938
MNDR hsa-miR-18b-5p Astrocytoma MNDR-E-MI-21939
MNDR hsa-miR-18b-5p Glioma MNDR-E-MI-21940
MNDR hsa-miR-18b-5p Amyotrophic lateral sclerosis MNDR-E-MI-21941
MNDR hsa-miR-18b-5p Osteosarcoma MNDR-E-MI-21942
MNDR hsa-miR-18b-5p Liposarcoma MNDR-E-MI-21943
MNDR hsa-miR-18b-5p Infarction middle cerebral artery MNDR-E-MI-21944
MNDR hsa-miR-18b-5p Stomach adenocarcinoma MNDR-E-MI-21945
MNDR hsa-miR-18b-5p Lung squamous cell carcinoma MNDR-E-MI-21946
MNDR hsa-miR-18b-5p Non-small cell lung adenocarcinoma MNDR-E-MI-21947
MNDR hsa-miR-18b-5p Lung adenocarcinoma MNDR-E-MI-21948
MNDR hsa-miR-18b-5p Thyroid carcinoma MNDR-E-MI-21949
MNDR hsa-miR-18b-5p Ovarian carcinoma MNDR-E-MI-21950
MNDR hsa-miR-18b-5p Pancreatic adenocarcinoma MNDR-E-MI-21951
MNDR hsa-miR-18b-5p Brain stem cancer MNDR-E-MI-21952
MNDR hsa-miR-18b-5p Carcinoma renal cell MNDR-E-MI-21953
MNDR hsa-miR-18b-5p Cholangiocarcinoma MNDR-E-MI-21954
MNDR hsa-miR-18b-5p Esophageal cancer MNDR-E-MI-21955
MNDR hsa-miR-18b-5p Lung small cell carcinoma MNDR-E-MI-21956
MNDR hsa-miR-18b-5p Head and neck squamous cell carcinoma MNDR-E-MI-21957
MNDR hsa-miR-18b-5p T acute lymphoblastic leukemia MNDR-E-MI-21958
MNDR hsa-miR-18b-5p Acute t cell leukemia MNDR-E-MI-21959
MNDR hsa-miR-18b-5p Fibromyalgia MNDR-E-MI-21960
MNDR hsa-miR-18b-5p Hepatocellular carcinoma MNDR-E-MI-21961
MNDR hsa-miR-18b-5p Familiar ovarian carcinoma MNDR-E-MI-21962
MNDR hsa-miR-18b-5p B-cell lymphoma MNDR-E-MI-21963
MNDR hsa-miR-18b-5p Retinoblastoma MNDR-E-MI-21964
MNDR hsa-miR-18b-5p Hodgkin lymphoma MNDR-E-MI-21965
MNDR hsa-miR-18b-5p Colorectal cancer MNDR-E-MI-21966
MNDR hsa-miR-18b-5p Multiple myeloma MNDR-E-MI-21967
MNDR hsa-miR-18b-5p Ependymoma MNDR-E-MI-21968
MNDR hsa-miR-18b-5p Cardiomegaly MNDR-E-MI-21969
MNDR hsa-miR-18b-5p Nasopharyngeal cancer MNDR-E-MI-21970
MNDR hsa-miR-18b-5p Prostatic neoplasms MNDR-E-MI-21971
MNDR hsa-miR-18b-5p Subarachnoid hemorrhage traumatic MNDR-E-MI-21972
MNDR hsa-miR-18b-5p Stroke lacunar MNDR-E-MI-21973
MNDR hsa-miR-18b-5p Breast cancer her3+ negative MNDR-E-MI-21974
MNDR hsa-miR-18b-5p HPV MNDR-E-MI-21975
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter CCN2 Homo sapiens RR00294323
TOP